ZA200106500B - Process for the preparation of (2R)-2-propyloctanoic acid. - Google Patents
Process for the preparation of (2R)-2-propyloctanoic acid. Download PDFInfo
- Publication number
- ZA200106500B ZA200106500B ZA200106500A ZA200106500A ZA200106500B ZA 200106500 B ZA200106500 B ZA 200106500B ZA 200106500 A ZA200106500 A ZA 200106500A ZA 200106500 A ZA200106500 A ZA 200106500A ZA 200106500 B ZA200106500 B ZA 200106500B
- Authority
- ZA
- South Africa
- Prior art keywords
- acid
- carbon
- present
- optical purity
- platinum
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 30
- YCYMCMYLORLIJX-SNVBAGLBSA-N (2r)-2-propyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CCC YCYMCMYLORLIJX-SNVBAGLBSA-N 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 11
- 230000003287 optical effect Effects 0.000 claims description 27
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 5
- RXAINMDCYOMAHC-SNVBAGLBSA-N (2s)-2-prop-2-enyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC=C RXAINMDCYOMAHC-SNVBAGLBSA-N 0.000 claims description 3
- RXAINMDCYOMAHC-UHFFFAOYSA-N 2-prop-2-enyloctanoic acid Chemical compound CCCCCCC(C(O)=O)CC=C RXAINMDCYOMAHC-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 150000001875 compounds Chemical class 0.000 description 31
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000006317 isomerization reaction Methods 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- DUQSBRQHALCSLC-SNVBAGLBSA-N (2s)-2-prop-2-ynyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC#C DUQSBRQHALCSLC-SNVBAGLBSA-N 0.000 description 5
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- BROQXILFDWZSAC-UHFFFAOYSA-N 1,2-dimethylimidazolidine Chemical compound CC1NCCN1C BROQXILFDWZSAC-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DUQSBRQHALCSLC-UHFFFAOYSA-N 2-prop-2-ynyloctanoic acid Chemical compound CCCCCCC(C(O)=O)CC#C DUQSBRQHALCSLC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- ZCILODAAHLISPY-UHFFFAOYSA-N biphenyl ether Natural products C1=C(CC=C)C(O)=CC(OC=2C(=CC(CC=C)=CC=2)O)=C1 ZCILODAAHLISPY-UHFFFAOYSA-N 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- USMHBASMQJSQKZ-HNCPQSOCSA-N cyclohexanamine;(2s)-2-prop-2-enyloctanoic acid Chemical compound NC1CCCCC1.CCCCCC[C@H](C(O)=O)CC=C USMHBASMQJSQKZ-HNCPQSOCSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/42—Platinum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/18—Carbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3975899 | 1999-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200106500B true ZA200106500B (en) | 2003-02-07 |
Family
ID=12561862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200106500A ZA200106500B (en) | 1999-02-18 | 2001-08-07 | Process for the preparation of (2R)-2-propyloctanoic acid. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6608221B1 (fr) |
EP (3) | EP1153910B1 (fr) |
JP (2) | JP4752989B2 (fr) |
KR (1) | KR100666423B1 (fr) |
CN (4) | CN101100422A (fr) |
AT (1) | ATE359256T1 (fr) |
AU (1) | AU776927B2 (fr) |
BR (1) | BR0008261A (fr) |
CA (1) | CA2364308C (fr) |
DE (1) | DE60034316T2 (fr) |
ES (1) | ES2283287T3 (fr) |
HU (1) | HUP0200358A3 (fr) |
MX (1) | MXPA01008241A (fr) |
NO (1) | NO20013971D0 (fr) |
NZ (1) | NZ513569A (fr) |
RU (1) | RU2297406C2 (fr) |
TW (1) | TWI268921B (fr) |
WO (1) | WO2000048982A1 (fr) |
ZA (1) | ZA200106500B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
JP4178405B2 (ja) | 2001-07-18 | 2008-11-12 | 小野薬品工業株式会社 | 脳虚血疾患治療剤 |
JP2005298334A (ja) * | 2001-12-19 | 2005-10-27 | Ono Pharmaceut Co Ltd | 新規な中間体化合物およびそれを用いる化合物の製造方法 |
US7928143B2 (en) * | 2003-10-03 | 2011-04-19 | Ono Pharmaceutical Co., Ltd. | Method for preventing and/or treating neurodegenerative diseases |
BRPI0415001A (pt) * | 2003-10-03 | 2006-11-07 | Ono Pharmaceutical Co | droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo |
JP4715516B2 (ja) * | 2003-10-03 | 2011-07-06 | 小野薬品工業株式会社 | (2r)−2−プロピルオクタン酸を有効成分とする輸液製剤 |
EP1741697B1 (fr) | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Cristal comprenant un acide (2r)-2-propyloctanoique et dibenzylamine |
KR20070085379A (ko) * | 2004-11-16 | 2007-08-27 | 머크 앤드 캄파니 인코포레이티드 | 뇌졸중 치료용 (2r)-2-프로필옥탄산의 프로드럭 |
JPWO2006075596A1 (ja) * | 2005-01-13 | 2008-06-12 | 株式会社クラレ | 2−アリルカルボン酸化合物の製造方法 |
EP2072047A1 (fr) | 2005-03-15 | 2009-06-24 | Ono Pharmaceutical CO., LTD. | Agent thérapeutique pour maladie ophtalmique |
EP2465499A3 (fr) | 2005-06-27 | 2013-02-13 | Ono Pharmaceutical Co., Ltd. | Agent thérapeutique pour traiter la douleur |
AU2006305309A1 (en) | 2005-10-18 | 2007-04-26 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
US20090203783A1 (en) | 2005-12-22 | 2009-08-13 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for acute cerebral infarct |
US20090118542A1 (en) * | 2006-02-16 | 2009-05-07 | Shigeya Yamazaki | Process for Production of Optically Active Carboxlic Acid Compound |
US20090325862A1 (en) * | 2006-05-04 | 2009-12-31 | Christian Steinkuhler | Histone Deacetylase Inhibitors for the Treatment of Neurodegeneration |
CN102417445B (zh) * | 2011-11-05 | 2013-11-13 | 中国科学院山西煤炭化学研究所 | 一种由马来酸合成丁二酸的方法 |
CN102675166B (zh) * | 2012-05-11 | 2014-03-26 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
CN102786407B (zh) * | 2012-08-15 | 2014-04-16 | 湖北大学 | 一种制备(2r)-2-丙基辛酸的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2317019A1 (de) * | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
JPH0672123B2 (ja) * | 1986-08-21 | 1994-09-14 | セントラル硝子株式会社 | トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法 |
JP2868183B2 (ja) * | 1988-02-29 | 1999-03-10 | 株式式社三和化学研究所 | 光学活性を有する4−オキソ−1−ベンゾピラン−2−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法 |
TW248552B (fr) * | 1993-06-01 | 1995-06-01 | Onoda Yakuhin Kogyo Kk | |
JP3032447B2 (ja) * | 1995-04-24 | 2000-04-17 | 小野薬品工業株式会社 | 光学活性な2−プロピルオクタン酸の製造方法 |
JP3084345B2 (ja) * | 1995-04-26 | 2000-09-04 | 小野薬品工業株式会社 | 光学活性な2−プロピルオクタン酸の製造方法 |
TW509672B (en) * | 1998-05-12 | 2002-11-11 | Ono Pharmaceutical Co | Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives |
TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
EP1741697B1 (fr) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Cristal comprenant un acide (2r)-2-propyloctanoique et dibenzylamine |
-
2000
- 2000-02-16 TW TW089102580A patent/TWI268921B/zh not_active IP Right Cessation
- 2000-02-17 CN CNA2006100997275A patent/CN101100422A/zh active Pending
- 2000-02-17 EP EP00904007A patent/EP1153910B1/fr not_active Expired - Lifetime
- 2000-02-17 AT AT00904007T patent/ATE359256T1/de not_active IP Right Cessation
- 2000-02-17 JP JP2000599723A patent/JP4752989B2/ja not_active Expired - Fee Related
- 2000-02-17 NZ NZ513569A patent/NZ513569A/xx not_active IP Right Cessation
- 2000-02-17 ES ES00904007T patent/ES2283287T3/es not_active Expired - Lifetime
- 2000-02-17 HU HU0200358A patent/HUP0200358A3/hu unknown
- 2000-02-17 US US09/890,651 patent/US6608221B1/en not_active Expired - Fee Related
- 2000-02-17 CA CA002364308A patent/CA2364308C/fr not_active Expired - Fee Related
- 2000-02-17 CN CNB008040133A patent/CN1183082C/zh not_active Expired - Fee Related
- 2000-02-17 MX MXPA01008241A patent/MXPA01008241A/es active IP Right Grant
- 2000-02-17 KR KR1020017010357A patent/KR100666423B1/ko not_active IP Right Cessation
- 2000-02-17 CN CNA2006101002245A patent/CN1907938A/zh active Pending
- 2000-02-17 EP EP06012511A patent/EP1714956A1/fr not_active Withdrawn
- 2000-02-17 EP EP06012510A patent/EP1721882A1/fr not_active Withdrawn
- 2000-02-17 AU AU25730/00A patent/AU776927B2/en not_active Ceased
- 2000-02-17 BR BR0008261-9A patent/BR0008261A/pt not_active Application Discontinuation
- 2000-02-17 DE DE60034316T patent/DE60034316T2/de not_active Expired - Lifetime
- 2000-02-17 RU RU2001125501/04A patent/RU2297406C2/ru active
- 2000-02-17 WO PCT/JP2000/000900 patent/WO2000048982A1/fr active IP Right Grant
- 2000-02-17 CN CNB2004100927127A patent/CN100430364C/zh not_active Expired - Fee Related
-
2001
- 2001-08-07 ZA ZA200106500A patent/ZA200106500B/en unknown
- 2001-08-15 NO NO20013971A patent/NO20013971D0/no not_active Application Discontinuation
-
2010
- 2010-05-20 JP JP2010116000A patent/JP5343925B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2364308C (fr) | Procede de preparation d'acide (2r)-2-propyloctanoique | |
CN106916060B (zh) | 一种高纯度对羟基苯乙酮的制备方法 | |
CN109796326A (zh) | 一种3-羟基丁酸盐的制备方法 | |
HU229188B1 (hu) | Új eljárás N-[(S)-1-karboxibutil]-(S)-alanin-észterek elõállítására, és a perindopril szintézisnél történõ alkalmazása | |
JP3716376B2 (ja) | 光学分割剤およびそれを用いた光学活性3−アミノピロリジン誘導体の製造法 | |
US4400533A (en) | Method of preparing d,l-phenylalanine | |
CN111875666B (zh) | 一种合成爱德万甜的方法 | |
JPH0717610B2 (ja) | ▲l▼−オクタヒドロイソキノリン誘導体のラセミ化方法 | |
EP1163205B1 (fr) | Procede de preparation de 1-chloro-2,4-diaminobenzene | |
JP3819560B2 (ja) | ハロゲン化フェニルプロピオン酸化合物の製造方法 | |
JPS6365053B2 (fr) | ||
JP3971875B2 (ja) | トランス−4−(4’−オキソシクロヘキシル)シクロヘキサノール類の製造方法 | |
JPH0113461B2 (fr) | ||
JPS6156222B2 (fr) | ||
JP2007223964A (ja) | 4−(n−エチル−n−イソプロピルアミノ)アニリンの精製方法 | |
JPH03127752A (ja) | メチルシクロヘキサノンの製造方法 | |
JPH08295644A (ja) | 9−フルオレニルメタノールの製法 | |
JPS63264567A (ja) | 2,3−ジメチルインドリンの製造方法 | |
JPS6075460A (ja) | パ−ヒドロイソキノリンの製造法 | |
JPH0329773B2 (fr) | ||
JPH02121938A (ja) | ボルナン−3−スピロ−1’−シクロペンタン−2−オールの製造法 | |
JPH01311086A (ja) | 3−クロロセフアロスポリン化合物の製造法 | |
JPH09169678A (ja) | ベンジルアルコールの製造方法 |